Gabify: Redefining Child Developmental Care & Inclusion in India

Millions of Indian children live with undetected autism, ADHD, and speech disorders — not because care doesn't exist, but because the system was never built to reach them. Gabify is changing that. And now, India's most credible industry body for disability inclusion has taken notice.
By Sahil Chopra, Founder & CEO, Gabify|May 2026

The Children India Forgot to Count

There is a child in a small town in Andhra Pradesh whose mother has noticed something. He doesn't point at things. He doesn't turn when she calls his name. He is two years old, and something feels different.

She asks her local doctor. The doctor says wait. She waits. He turns three. She asks again. The nearest specialist is four hours away. The appointment is six months out. By the time she gets there, the window for the most effective early intervention has quietly narrowed.

This story is not unusual. It is the lived reality of millions of families across India — and it reflects a systemic failure that has been decades in the making.

1 in 8 children in India is affected by a neurodevelopmental condition — autism, ADHD, speech delay, or related disorders

15% of India's population lives with some form of communication disorder

1 : 10,000 the ratio of speech therapists to people in India — among the most severe specialist shortages in healthcare

The numbers are staggering. But what they fail to capture is the human weight behind each data point — the parent who didn't know what to look for, the child whose potential was left untapped, the therapist who was stretched impossibly thin across a caseload no one person should carry.

Early identification — catching developmental differences before age five — is widely recognised by clinical research as the single highest-leverage intervention in neurodevelopmental care. Miss that window, and the effort required to achieve the same developmental outcomes multiplies exponentially.

India is missing that window. Every. Single. Day. For hundreds of thousands of children.

What Disability Inclusion Actually Means — and Why Most Institutions Get It Wrong

The phrase 'disability inclusion' has been adopted enthusiastically by organisations across India's corporate and policy landscape. Ramps. Reserved seating. Sensitisation workshops. These are not wrong — but they are incomplete.

True inclusion is not accommodation. It is access — to opportunity, to care, to early identification — at the moment it matters most. And for a child with autism, that moment is not at the age of recruitment. It is at the age of two.

Disability inclusion, done right, asks a harder question: where in the system do people with disabilities first encounter a door that is closed to them? For millions of Indian children, that door is closed at diagnosis — or rather, at the absence of one.

"Inclusion isn't just about making space for people with disabilities at the table. It begins much earlier — with knowing they exist, identifying them early, and giving their families the tools to act before the window closes."
— Sahil Chopra, Founder & CEO, Gabify

This is why Gabify was built. Not to create a better therapy app. But to redesign the first and most critical layer of the inclusion pipeline: the moment of recognition.

Gabify's Model: AI That Sees What the System Has Been Missing

Founded in 2024, Gabify is an AI-powered platform for early detection and therapy of speech and neurodevelopmental disorders in children. But the elevator pitch doesn't capture what makes Gabify genuinely different.

Most screening tools are checklists. Gabify's flagship product, Neurolens, is a clinical intelligence system.

Neurolens: What It Does

Powered by Gaby — Gabify's proprietary AI — Neurolens uses a multi-modal approach combining speech recognition, facial analysis, and eye-tracking to analyse 189 behavioural parameters across 9 clinical domains. It generates objective, personalised developmental profiles for children from as young as 8 months old.

The clinical frameworks underpinning it — DSM-5, ADOS, and others — are the same gold standards used by child psychiatrists and developmental paediatricians. What Gabify does is translate the intelligence of those frameworks into a mobile-based assessment that can be completed in minutes, not months.

What typically requires weeks of clinical visits, specialist referrals, and significant family expense can now be done in a structured, expert-guided session at a partner therapy centre — generating a multi-language report that parents can understand and clinicians can act on.

Why Clinical Integrity Is Non-Negotiable

Here is something most EdTech and HealthTech companies will not say openly: screening tools can cause harm if misused.

A false positive can cause a family years of unnecessary anxiety and misguided intervention. A false negative can cause a child to miss critical support. Gabify made a deliberate, values-driven decision to restrict Neurolens access exclusively to RCI-registered clinicians and expert-led centres.

"We made the decision to step back from non-expert-led deployments even when it cost us scale. That decision was right. Inclusion cannot be built on shaky clinical foundations."
— Sahil Chopra, Founder & CEO, Gabify

This is a harder path. It slows adoption. But it is the path that builds genuine trust with clinicians, families, and regulators — and it is the path that produces outcomes.

Traction That Speaks

Gabify is not a promise. It is a proof of concept that is already at scale:

2,500+ children screened across India
100+ partner therapy centres across 50+ cities
300+ RCI-registered clinicians on the platform
Multilingual reports delivered in all major Indian languages
AIIMS New Delhi and ICMR clinical validation — the most credible research imprimatur in Indian healthcare
Andhra Pradesh Government partnership for a 10,000-child mass screening programme — in final stages

And coming in July 2026: Connect by Gabify — a companion platform at gabify.care that connects parents directly with vetted therapy centres, removing the single biggest barrier families face after a positive screen: knowing where to go next.

CII's 'Inclusion in Action': Why This Recognition Matters

In May 2026, the Confederation of Indian Industry — India's most influential industry association — released a landmark publication through its India Business and Disability Network (IBDN): Inclusion in Action, a curated compendium of exemplary inclusive practices unveiled at the CII Awards for Excellence in Disability Inclusion 2026.

Gabify was selected as one of the featured organisations.

To understand why this matters, you need to understand what CII-IBDN represents. This is not a startup award or a feel-good recognition. IBDN is the premier platform at the intersection of Indian business and disability rights, engaging corporations, policymakers, and civil society in shaping how India thinks about and operationalises inclusion at scale.

The compendium was explicitly designed, in CII's own words, to showcase practices with the "potential to influence the broader inclusion ecosystem across India."

That framing matters. Gabify was not included as a startup success story. It was included as a model — a replicable approach to inclusion that goes deeper and reaches further than conventional thinking.

What CII Specifically Highlighted

The compendium showcased Gabify's continuum-of-care model — one that doesn't stop at the clinic door. It recognised:

AI-enabled, multi-modal screening that generates objective developmental profiles at scale
A care model that makes parents active co-therapists, with home-based therapy tools integrated into daily routines
Community engagement through schools, workshops, and digital content that confronts the stigma and denial that delays families from seeking help
Therapist enablement — AI handling routine tracking so clinicians can focus on clinical judgment and human connection
A stated goal of impacting one million lives by 2028

"Therapists can focus on clinical judgment and meaningful connections while the system handles routine tracking and insights. The real promise lies in time saved for parents and returned to children who need early support. Our goal is to impact one million lives by 2028."
— Vasyl Leshchuk, Co-Founder & CTO, Gabify

This is what CII saw in Gabify: not just a product, but a philosophy of inclusion — one that is upstream, systemic, and designed for the scale India demands.

What It Means to Lead on Inclusion

India is at an inflection point on disability inclusion. The Rights of Persons with Disabilities Act (2016), the National Policy for Persons with Disabilities, and growing corporate ESG commitments have created genuine momentum. But momentum without early identification is scaffolding with no foundation.

If a child is not identified early, they don't show up in inclusion programmes. They don't get therapy. They don't develop the skills that would allow them to participate — in school, in work, in life. The inclusion conversation that happens at age 22, at the point of employment, is downstream of everything we failed to do at age 2.

Gabify's entry into this space — and CII's recognition of it — signals something important: India's inclusion movement is beginning to ask the harder, earlier question. Where does exclusion begin? And how do we intervene before it becomes permanent?

"We are not just solving a medical problem. We are addressing hesitation, denial, and misinformation by working with schools and communities to normalise early intervention. Inclusion starts with awareness."
— Sahil Chopra, Founder & CEO, Gabify

Gabify: Redefining Child Developmental Care & Inclusion in India - CII

Being featured alongside India's leading corporations, foundations, and institutions in a CII publication is not something Gabify takes lightly. It represents external validation that our model — clinically grounded, tech-enabled, community-rooted — has earned its place in India's national inclusion conversation.

But more than a recognition, it is a responsibility. To continue building with integrity. To scale without compromising clinical standards. To reach the children who are still waiting.

The Road Ahead

We are a young company carrying a large mission. The Andhra Pradesh government partnership — a 10,000-child mass screening programme — is a proof of what government-technology collaboration can achieve at scale. Connect by Gabify will, for the first time, create a seamless path from identification to care access for parents across India.

The franchise model we are building will bring Gabify-branded Child Wellness and Development Labs to Tier 2 and Tier 3 cities — making specialist-grade screening physically present in the communities that need it most.

And the research we are conducting, in partnership with AIIMS and ICMR, will continue to deepen the clinical validation that makes everything else possible.

The diagnosis gap in India is real. So is the opportunity to close it.

About Gabify

Gabify (Sahchi Hearing & Speech Solutions Pvt. Ltd.) is an AI-powered platform for early detection and therapy of speech and neurodevelopmental disorders in children. Validated by AIIMS New Delhi and ICMR under the NCAT initiative, Gabify's flagship product Neurolens screens children across 189 behavioural parameters in 9 clinical domains. Backed by IPV Ventures, Gabify has screened 2,500+ children across 50+ cities, operates through 100+ partner therapy centres and 300+ RCI-registered clinicians, and was recognised by CII's India Business and Disability Network in its national 'Inclusion in Action' compendium (2026). Gabify is a DPIIT-recognised startup and has been acknowledged by NITI Aayog, UNICEF, STPI, and the Ministry of Education.